CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on enhancing cancer immunotherapy by normalizing tumor stiffness using engineered live biotherapeutics. These programmable bacteria deliver enzymes to improve blood flow and oxygen supply in tumors, potentially increasing the effectiveness of immune checkpoint inhibitors in treating colorectal and…
Immunotherapy, including immune checkpoint inhibitors (ICIs), has revolutionized the treatment of multiple cancers.
Anti-tumor responses are often durable but overall only a subset of patients receiving ICIs has exhibited sustained tumor shrinkage, whereas a substantial fraction receiving these therapies develops immune-related adverse events.
The absence of dramatic responses is attributed to several factors, including abnormalities in the tumor microenvironment (TME).
Specifically, many tumors…
UNIVERSITY OF CYPRUS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
